Viewing Study NCT00470067


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-05-03 @ 5:59 AM
Study NCT ID: NCT00470067
Status: TERMINATED
Last Update Posted: 2014-08-22
First Post: 2007-05-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent endometrial carcinoma View
None stage III endometrial carcinoma View
None stage IV endometrial carcinoma View